Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?

by Peter Joseph Jongen, Keith Wesnes, Björn van Geel, Paul Pop, Hans Schrijver, Leo H. Visser, H. Jacobus Gilhuis, Ludovicus G. Sinnige, Augustina M. Brands
Published 2015-01-01

Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remi...

by Peter Joseph Jongen, Keith Wesnes, Björn van Geel, Paul Pop, Evert Sanders, Hans Schrijver, Leo H Visser, H Jacobus Gilhuis, Ludovicus G Sinnige, Augustina M Brands, COGNISEC Study Group
Published 2014-01-01

Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice.

by Peter Joseph Jongen, Christian Sindic, Evert Sanders, Stanley Hawkins, Wim Linssen, Erik van Munster, Stephan Frequin, George Borm, Functional Composite and Quality of Life in Avonex-treated Relapsing Multiple Sclerosis Patients Study Group
Published 2011-01-01

Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A si...

by Peter Joseph Jongen, Ghislaine A van Mastrigt, Marco Heerings, Leo H Visser, Rob P Ruimschotel, Astrid Hussaarts, Lotte Duyverman, Joyce Valkenburg-Vissers, Job Cornelissen, Michel Bos, Maarten van Droffelaar, Rogier Donders
Published 2019-01-01

Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.

by Andrea Giordano, Katrin Liethmann, Sascha Köpke, Jana Poettgen, Anne Christin Rahn, Jelena Drulovic, Yesim Beckmann, Jaume Sastre-Garriga, Ian Galea, Marco Heerings, Peter Joseph Jongen, Eik Vettorazzi, Alessandra Solari, Christoph Heesen, AutoMS group
Published 2018-01-01